Syra Health announces voluntarily delisting from NASDAQ

Syra Health (SYRA) announced that it has given formal notice to the Nasdaq Stock Market of its intention to voluntarily delist its common stock from the Nasdaq Capital Market. The Company currently anticipates that it will file with the SEC a Form 25, Notification of Removal of Listing and/or Registration Under Section 12 the Exchange Act, relating to the delisting on or about April 11, with the delisting of its common stock taking effect no earlier than ten days thereafter. As a result, the Company expects that the last trading day of its common stock on the Nasdaq Capital Market will be on or about April 21. Following a thorough and extensive evaluation, the Executive Management team and Board of Directors have decided that a delisting is warranted, and a strategic pause will allow for improved focus on strengthening the Company’s core fundamentals while reducing the Company’s costs associated with a Nasdaq listing.